Back to Results
First PageMeta Content
Clinical research / Medical ethics / Pharmacology / Dapoxetine / Premature ejaculation / Paroxetine / Placebo / Medicine / Selective serotonin reuptake inhibitors / Bioethics


Priligy Art[removed]AR for EPAR
Add to Reading List

Document Date: 2013-07-21 06:29:07


Open Document

File Size: 362,24 KB

Share Result on Facebook

City

London / /

Company

Janssen-Cilag AB / /

Country

Germany / Romania / Hungary / Netherlands / Italy / Estonia / Slovenia / Bulgaria / Cyprus / Latvia / Sweden / Poland / Norway / Belgium / France / Austria / Iceland / Portugal / Slovakia / United Kingdom / Malta / Lithuania / Luxembourg / Finland / Spain / Greece / Ireland / Denmark / Czech Republic / /

/

Event

FDA Phase / /

Facility

Canary Wharf / Janssen-Cilag AB INN / /

IndustryTerm

medicinal product / /

MedicalCondition

loss of consciousness / headache / nausea / CMD / syncope / fatigue / obesity / asystole / bradycardia / insomnia / disease / depressive disorder / pain / dizziness / depression / /

Organization

E-mail info@ema.europa.eu Website www.ema.europa.eu An / European Medicines Agency / European Union / /

/

Position

Baseline Observation Carried Forward / mg p.r.n. / Major / forward / /

Product

dapoxetine / Priligy / /

ProvinceOrState

Prince Edward Island / /

URL

www.ema.europa.eu / /

SocialTag